Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Fentanyl price, strengths & recalls

Pharmacies pay $5,689.31 for 360 hs of Fentanyl 0.075 mg/hr (72 hr) patch this week, and from $87.97 to $20,766.96 across its 10 priced strengths and forms. 9 manufacturers make it. It is in shortage (unavailable). 22 recalls are ongoing. Its official label last changed on March 30, 2026.

Unavailable22 open recallsGeneric
Pharmacies pay$5,689.31for 360 hs of 0.075 mg/hr (72 hr) patch-0.4% in 4 weeks
Fair cash price
$6,553.21
Strengths
10
Makers
9
Updated
Nov 11

Fentanyl price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
0.05 mg/mL, 2 mL injection$1.76$87.97 / 50 mL-1.5%+51.9%
0.05 mg/mL, 5 mL injection$1.76$87.97 / 50 mL-1.5%+51.9%
0.05 mg/mL, 50 mL injection$1.76$87.97 / 50 mL-1.5%+51.9%
0.012 mg/hr (72 hr) patch$9.37$3,372.34 / 360 hs+4.2%+3.0%
0.025 mg/hr (72 hr) patch$6.07$2,184.98 / 360 hs+0.9%+9.1%
0.0375 mg/hr (72 hr) patch$36.19$13,027.63 / 360 hs+3.3%-14.7%
0.05 mg/hr (72 hr) patch$9.07$3,266.46 / 360 hsNo change-4.8%
0.0625 mg/hr (72 hr) patch$57.69$20,766.96 / 360 hsNo change
0.075 mg/hr (72 hr) patch$15.80$5,689.31 / 360 hs-0.4%+15.6%
0.1 mg/hr (72 hr) patch$19.62$7,061.71 / 360 hs+6.9%+10.4%

Supply status: shortages & recalls

In shortage20 products are short or being discontinued
12 ongoing recalls356 recalls on record, latest Sep 16, 2026

Shortages

  • Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
  • Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)Hospira, Inc., a Pfizer Company · Limited Availability · Reason: Demand increase for the drug · Updated Nov 9, 2026Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026
  • Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)Hospira, Inc., a Pfizer Company · Available · Updated Nov 9, 2026
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)Fresenius Kabi USA, LLC · Unavailable · Reason: Other · Updated Nov 3, 2026Next release December 2026. Check wholesalers for inventory.
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory
  • Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)Fresenius Kabi USA, LLC · Available · Updated Nov 3, 2026Check wholesalers for inventory

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 356 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for fentanyl? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedMarch 30, 2026
Version13 of 11
EffectiveDec 26, 2025
Read the label

These highlights do not include all the information needed to use FENTANYL CITRATE INJECTION safely and effectively. See full prescribing information for FENTANYL CITRATE INJECTION.Fentanyl Citrate Injection, for intravenous or intramuscular use, CIIInitial U.S. Approval: 1968

This drug has a boxed warning

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM

USE OF FENTANYL CITRATE INJECTION

Addiction, Abuse, and Misuse

Because the use of Fentanyl Citrate Injection exposes patients and other users to the risks of opioid addiction, abuse and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)].

Life-Threatening Respiratory Depression

Serious, life-threatening, or fatal respiratory depression may occur with use of Fentanyl Citrate Injection, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Fentanyl Citrate Injection are essential [see Warnings and Precautions (5.2)].

Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS)

depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of Fentanyl Citrate Injection and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.4), Drug Interactions (7)].

Cytochrome P450 3A4 Interaction

The concomitant use of Fentanyl Citrate Injection with all cytochrome P450 3A4 inhibitors may result in an increase in fentanyl plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in fentanyl plasma concentration. Monitor patients receiving Fentanyl Citrate Injection and any CYP3A4 inhibitor or inducer [see Warnings and Precautions (5.3), Drug Interactions (7), Clinical Pharmacology (12.3)]

WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF FENTANYL CITRATE INJECTION

See full prescribing information for complete boxed warning.

Fentanyl Citrate Injection exposes users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient's risk before prescribing and monitor regularly for these behaviors and conditions (5.1)

Serious, life-threatening, or fatal respiratory depression may occur with use of Fentanyl Citrate Injection, especially during initiation

or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of Fentanyl Citrate Injection are essential. (5.2)

Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. (5.3, 7)

Concomitant use with CYP3A4 inhibitors (or discontinuation of CYP3A4 inducers) can result in a fatal overdose of fentanyl. (5.4, 7, 12.3)

Recent major changes (as listed on the label)

Dosage and Administration (2.1) 12/2025

Warnings and Precautions (5.2, 5.3, 5.11) 12/2025

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA019101 · Hikma
First approved
July 11, 1984 (42 years ago)
Latest approved change
December 22, 2025
Approved label
PDF, Jan 6, 2026
Generic makers
5 approved generic applications on the market

Fentanyl questions

How much does fentanyl cost without insurance?

Pharmacies pay about $5,689.31 for 360 hs of fentanyl 0.075 mg/hr (72 hr) patch ($15.80 per unit). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $6,553.21. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is fentanyl in shortage?

Yes. 20 products are listed as in shortage or being discontinued (unavailable). See which ones.

Has fentanyl been recalled?

356 recalls on record, 22 ongoing. Recalls name specific lots - check yours.

When did the fentanyl label last change?

The official label was last updated on March 30, 2026 (version 13). See what changed.

Talk about fentanyl

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.